FDA Approves Drug to Reduce Heart Attack Risk in People With Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce the risk of serious cardiovascular … Read More The post FDA Approves Drug to Reduce Heart Attack Risk in People With Type 2 Diabetes appeared first on ProPakistani .
We haven't written up this one. ProPakistani has the full story — the link below goes straight to it.